435 related articles for article (PubMed ID: 25983251)
41. Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality?
Mungo B; Molena D; Stem M; Yang SC; Battafarano RJ; Brock MV; Lidor AO
Dis Esophagus; 2015 Oct; 28(7):644-51. PubMed ID: 25059343
[TBL] [Abstract][Full Text] [Related]
42. Differences in reported esophageal cancer resection outcomes between national clinical and administrative databases.
Lapar DJ; Stukenborg GJ; Lau CL; Jones DR; Kozower BD
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1152-7. PubMed ID: 22938777
[TBL] [Abstract][Full Text] [Related]
43. The surgical revolving door: risk factors for hospital readmission.
Morris DS; Rohrbach J; Rogers M; Thanka Sundaram LM; Sonnad S; Pascual J; Sarani B; Reilly P; Sims C
J Surg Res; 2011 Oct; 170(2):297-301. PubMed ID: 21696766
[TBL] [Abstract][Full Text] [Related]
44. Hospital variation in readmission after coronary artery bypass surgery in California.
Li Z; Armstrong EJ; Parker JP; Danielsen B; Romano PS
Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):729-37. PubMed ID: 22949489
[TBL] [Abstract][Full Text] [Related]
45. Complication rates following elective lumbar fusion in patients with diabetes: insulin dependence makes the difference.
Golinvaux NS; Varthi AG; Bohl DD; Basques BA; Grauer JN
Spine (Phila Pa 1976); 2014 Oct; 39(21):1809-16. PubMed ID: 25010098
[TBL] [Abstract][Full Text] [Related]
46. Risk factors for readmission of orthopaedic surgical patients.
Dailey EA; Cizik A; Kasten J; Chapman JR; Lee MJ
J Bone Joint Surg Am; 2013 Jun; 95(11):1012-9. PubMed ID: 23780539
[TBL] [Abstract][Full Text] [Related]
47. Unplanned readmissions and survival following brain tumor surgery.
Dickinson H; Carico C; Nuño M; Mukherjee D; Ortega A; Black KL; Patil CG
J Neurosurg; 2015 Jan; 122(1):61-8. PubMed ID: 25343184
[TBL] [Abstract][Full Text] [Related]
48. The clinical and economic costs of delirium after surgical resection for esophageal malignancy.
Markar SR; Smith IA; Karthikesalingam A; Low DE
Ann Surg; 2013 Jul; 258(1):77-81. PubMed ID: 23426343
[TBL] [Abstract][Full Text] [Related]
49. Readmission incidence and associated factors after a hepatic resection at a major hepato-pancreatico-biliary academic centre.
Spolverato G; Ejaz A; Kim Y; Weiss M; Wolfgang CL; Hirose K; Pawlik TM
HPB (Oxford); 2014 Nov; 16(11):972-8. PubMed ID: 24712690
[TBL] [Abstract][Full Text] [Related]
50. Morbidity and mortality after esophagectomy following neoadjuvant chemoradiation.
Merritt RE; Whyte RI; D'Arcy NT; Hoang CD; Shrager JB
Ann Thorac Surg; 2011 Dec; 92(6):2034-40. PubMed ID: 21945223
[TBL] [Abstract][Full Text] [Related]
51. Association of perioperative fluid balance and adverse surgical outcomes in esophageal cancer and esophagogastric junction cancer.
Wei S; Tian J; Song X; Chen Y
Ann Thorac Surg; 2008 Jul; 86(1):266-72. PubMed ID: 18573435
[TBL] [Abstract][Full Text] [Related]
52. Readmissions after major cancer surgery among older adults.
Langan RC; Huang CC; Colton S; Potosky AL; Johnson LB; Shara NM; Al-Refaie WB
Surgery; 2015 Aug; 158(2):428-37. PubMed ID: 26003911
[TBL] [Abstract][Full Text] [Related]
53. 30-day readmission for patients undergoing percutaneous coronary interventions in New York state.
Hannan EL; Zhong Y; Krumholz H; Walford G; Holmes DR; Stamato NJ; Jacobs AK; Venditti FJ; Sharma S; King SB
JACC Cardiovasc Interv; 2011 Dec; 4(12):1335-42. PubMed ID: 22192374
[TBL] [Abstract][Full Text] [Related]
54. Predictors and impacts of hospital readmissions following liver transplantation.
Yataco M; Cowell A; David W; Keaveny AP; Taner CB; Patel T
Ann Hepatol; 2016; 15(3):356-62. PubMed ID: 27049489
[TBL] [Abstract][Full Text] [Related]
55. Temporal variability of readmission determinants in postoperative vascular surgery patients.
Lin MJ; Baky F; Housley BC; Kelly N; Pletcher E; Balshi JD; Stawicki SP; Evans DC
J Postgrad Med; 2016; 62(4):216-222. PubMed ID: 27763477
[TBL] [Abstract][Full Text] [Related]
56. Adverse Effect of Post-Discharge Care Fragmentation on Outcomes after Readmissions after Liver Transplantation.
Kothari AN; Loy VM; Brownlee SA; Ezure Y; Schaidle-Blackburn C; Cotler SJ; di Sabato D; Kuo PC; Lu AD
J Am Coll Surg; 2017 Jul; 225(1):62-67. PubMed ID: 28400298
[TBL] [Abstract][Full Text] [Related]
57. Early versus late readmission after surgery among patients with employer-provided health insurance.
Kim Y; Gani F; Lucas DJ; Ejaz A; Spolverato G; Canner JK; Schneider EB; Pawlik TM
Ann Surg; 2015 Sep; 262(3):502-11; discussion 509-11. PubMed ID: 26258319
[TBL] [Abstract][Full Text] [Related]
58. Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Li SH; Huang EY; Lu HI; Huang WT; Yen CC; Huang WC; Chen CH
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1352-9, 1359.e1. PubMed ID: 22841170
[TBL] [Abstract][Full Text] [Related]
59. Prediction of major pulmonary complications after esophagectomy.
Ferguson MK; Celauro AD; Prachand V
Ann Thorac Surg; 2011 May; 91(5):1494-1500; discussion 1500-1. PubMed ID: 21524462
[TBL] [Abstract][Full Text] [Related]
60. Readmission to an intensive care unit after cardiac surgery: reasons and outcomes.
Jarząbek R; Bugajski P; Greberski K; Błaszczyński J; Słowińska-Jarząbek B; Kalawski R
Kardiol Pol; 2014; 72(8):740-7. PubMed ID: 24671911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
